Insurers Pay Millions For Ivermectin For COVID-19, Even Though The Drug Doesn’t Work

MONDAY, Jan. 17, 2022– U.S. insurers are paying millions of dollars a year to cover the cost of ivermectin for COVID-19 patients despite a lack of proof the anti-parasitic drug is effective against the virus, a new study finds. Both the U.S. Food and Drug Administration and the World Health Organization say ivermectin pills— typically used to treat parasitic…